Literature DB >> 21220691

Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells.

Alessandra Fragale1, Emilia Stellacci, Ramona Ilari, Anna Lisa Remoli, Angela Lanciotti, Edvige Perrotti, Iart Shytaj, Roberto Orsatti, Harshani R Lawrence, Nicholas J Lawrence, Jerry Wu, Michael Rehli, Keiko Ozato, Angela Battistini.   

Abstract

Despite extensive studies that unraveled ligands and signal transduction pathways triggered by TLRs, little is known about the regulation of TLR gene expression. TLR3 plays a crucial role in the recognition of viral pathogens and induction of immune responses by myeloid DCs. IFN regulatory factor (IRF)-8, a member of the IRF family, is a transcriptional regulator that plays essential roles in the development and function of myeloid lineage, affecting different subsets of myeloid DCs. In this study, we show that IRF-8 negatively controls TLR3 gene expression by suppressing IRF-1- and/or polyinosinic-polycytidylic acid-stimulated TLR3 expression in primary human monocyte-derived DCs (MDDCs). MDDCs expressed TLR3 increasingly during their differentiation from monocytes to DCs with a peak at day 5, when TLR3 expression was further enhanced upon stimulation with polyinosinic-polycytidylic acid and then was promptly downregulated. We found that both IRF-1 and IRF-8 bind the human TLR3 promoter during MDDC differentiation in vitro and in vivo but with different kinetic and functional effects. We demonstrate that IRF-8-induced repression of TLR3 is specifically mediated by ligand-activated Src homology 2 domain-containing protein tyrosine phosphatase association. Indeed, Src homology 2 domain-containing protein tyrosine phosphatase-dephosphorylated IRF-8 bound to the human TLR3 promoter competing with IRF-1 and quashing its activity by recruitment of histone deacetylase 3. Our findings identify IRF-8 as a key player in the control of intracellular viral dsRNA-induced responses and highlight a new mechanism for negative regulation of TLR3 expression that can be exploited to block excessive TLR activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220691      PMCID: PMC4053178          DOI: 10.4049/jimmunol.1000918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages.

Authors:  F Rosenbauer; J F Waring; J Foerster; M Wietstruk; D Philipp; I Horak
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 2.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Authors:  Tomohiko Tamura; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

Review 3.  Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.

Authors:  Gerty Schreibelt; Jurjen Tel; Kwinten H E W J Sliepen; Daniel Benitez-Ribas; Carl G Figdor; Gosse J Adema; I Jolanda M de Vries
Journal:  Cancer Immunol Immunother       Date:  2010-03-05       Impact factor: 6.968

4.  SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes.

Authors:  B Kautz; R Kakar; E David; E A Eklund
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

5.  Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element.

Authors:  Takeshi Kuwata; Celine Gongora; Yuka Kanno; Kazuyasu Sakaguchi; Tomohiko Tamura; Tomohiko Kanno; Venkatesha Basrur; Robert Martinez; Ettore Appella; Todd Golub; Keiko Ozato
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Authors:  Liwei Chen; Daniele Pernazza; Latanya M Scott; Harshani R Lawrence; Yuan Ren; Yunting Luo; Xin Wu; Shen-Shu Sung; Wayne C Guida; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

8.  An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.

Authors:  I M Wang; C Contursi; A Masumi; X Ma; G Trinchieri; K Ozato
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Of mice and men: species variations of Toll-like receptor expression.

Authors:  Michael Rehli
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

10.  Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.

Authors:  Marco Sgarbanti; Alessandra Borsetti; Nicola Moscufo; Maria C Bellocchi; Barbara Ridolfi; Filomena Nappi; Giulia Marsili; Giovanna Marziali; Eliana M Coccia; Barbara Ensoli; Angela Battistini
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

View more
  14 in total

1.  Mutations in ZBTB20 cause Primrose syndrome.

Authors:  Viviana Cordeddu; Bert Redeker; Emilia Stellacci; Aldo Jongejan; Alessandra Fragale; Ted E J Bradley; Massimiliano Anselmi; Andrea Ciolfi; Serena Cecchetti; Valentina Muto; Laura Bernardini; Meron Azage; Daniel R Carvalho; Alberto J Espay; Alison Male; Anna-Maja Molin; Renata Posmyk; Carla Battisti; Alberto Casertano; Daniela Melis; Antoine van Kampen; Frank Baas; Marcel M Mannens; Gianfranco Bocchinfuso; Lorenzo Stella; Marco Tartaglia; Raoul C Hennekam
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

2.  Region-specific innate antiviral responses of the human epididymis.

Authors:  James A Browne; Shih-Hsing Leir; Scott E Eggener; Ann Harris
Journal:  Mol Cell Endocrinol       Date:  2018-01-13       Impact factor: 4.102

3.  The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation.

Authors:  Tsung-Hsien Chang; Songxiao Xu; Prafullakumar Tailor; Tomohiko Kanno; Keiko Ozato
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

4.  Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.

Authors:  Valentina E Schneeberger; Yuan Ren; Noreen Luetteke; Qingling Huang; Liwei Chen; Harshani R Lawrence; Nicholas J Lawrence; Eric B Haura; John M Koomen; Domenico Coppola; Jie Wu
Journal:  Oncotarget       Date:  2015-03-20

Review 5.  HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.

Authors:  Angela Battistini; Marco Sgarbanti
Journal:  Viruses       Date:  2014-04-14       Impact factor: 5.048

6.  Reciprocal regulation of TLR2-mediated IFN-β production by SHP2 and Gsk3β.

Authors:  Jin Hee Park; Ryeojin Ko; Soo Young Lee
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

7.  Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.

Authors:  Dong-Wen Lv; Kun Zhang; Renfeng Li
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

8.  Total cellular protein presence of the transcription factor IRF8 does not necessarily correlate with its nuclear presence.

Authors:  Hans Minderman; Orla Maguire; Kieran L O'Loughlin; Jason Muhitch; Paul K Wallace; Scott I Abrams
Journal:  Methods       Date:  2016-08-28       Impact factor: 3.608

9.  MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses.

Authors:  Siddhika Pareek; Saugata Roy; Bharti Kumari; Pratistha Jain; Arup Banerjee; Sudhanshu Vrati
Journal:  J Neuroinflammation       Date:  2014-05-29       Impact factor: 8.322

10.  HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections.

Authors:  Lei Sun; Zhengfan Jiang; Victoria A Acosta-Rodriguez; Michael Berger; Xin Du; Jin Huk Choi; Jianhui Wang; Kuan-Wen Wang; Gokhul K Kilaru; Jennifer A Mohawk; Jiexia Quan; Lindsay Scott; Sara Hildebrand; Xiaohong Li; Miao Tang; Xiaoming Zhan; Anne R Murray; Diantha La Vine; Eva Marie Y Moresco; Joseph S Takahashi; Bruce Beutler
Journal:  J Exp Med       Date:  2017-10-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.